Description
Developer of micro-implants technology intended for sustainable release of medicinal products. The company's technology is used for ophthalmological therapeutic and specializes in developing microdevices for releasing drug active substances for long periods of time, enabling healthcare professionals to treat their patients suffering from ophthalmological disorders.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Later Stage VC | 22-Dec-2021 | $937K | 00.000 | 00.000 | Completed | Generating Revenue |
1. Early Stage VC | 25-Nov-2019 | 00000 | 00000 | 00.000 | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Class D | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | ||
Class C | 000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Pascal Bertholet | Chief Operating Officer |
Name | Representing | Role | Since |
---|---|---|---|
Francois Meurgey | UniD Manufacturing | Board Member | 000 0000 |
Knoops Denis | Self | Board Member | 000 0000 |
Marc Foidart | Noshaq | Chairman | 000 0000 |
Rakic Jean-Marie | Self | Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Noshaq | Venture Capital | Minority | 000 0000 | 000000 0 | |
Qbic Fund | Venture Capital | Minority | 000 0000 | 000000 0 |